A new study reveals experimental drug XL20 crosses the blood-brain barrier to stop toxic TDP-43 clumping in ALS.

He started as a barber and went on to become one of the great inventors of Antiquity, directing the Museion of Alexandria and ...

Medtronic, through its subsidiary Covidien LLC, is pushing to expand the approved uses of its Hugo robotic-assisted surgery ...

There is a promising shift toward nonsurgical treatment strategies in early breast cancer, as clinicians aim to reduce harm ...

From foam rolling to viral jaw-release videos, fascia has become one of the biggest talking points in movement and wellbeing.

But any conversation about the boundary-pushing shonen anime is incomplete without Hiromu Arakawa’s Fullmetal Alchemist, which concluded its official manga serialization on June 11, 2010. While 16 ...

Physically, Homo sapiens is not that special in the animal world. But the species has discovered ways of finding food and beating the odds of survival in every habitat from jungle to Arctic wasteland.

It’s a regrettable reality that there is never enough time to cover all the interesting scientific stories we come across. So every month, we highlight a handful of the best stories that nearly ...

A first-in-human study has begun evaluating Shape Memory Medical's investigational False Lumen Embolization (FLE) System in aortic dissection. The FLE device uses a shape memory polymer scaffold ...

aDivision of Pediatric General, Thoracic, and Fetal Surgery, Department of Surgery, University of California Davis Health, Sacramento, CA, USA bCenter for Bioengineering in Medicine, School of ...

In utero treatment of myelomeningocele, the most severe form of spina bifida, with allogeneic, live stem cells was feasible and safe, a first-in-human, phase I trial suggested. All six infants had an ...

Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study We conducted a multicenter, open-label, ...